Wes Wheeler is President of UPS’s global Healthcare and Life Sciences (HCLS) unit.
UPS’s HCLS unit provides extensive supply chain management, cold chain, clinical trials, global transportation and other critical healthcare service operations. It includes Marken, Polar Speed, and the company’s 114 healthcare-dedicated facilities.
Wheeler joined UPS as part of the company’s acquisition of Marken in 2016. He started his career as a project manager for Exxon Research and Engineering. Since then, he has served in numerous leadership positions including vice president of marketing, senior vice president of global manufacturing and supply at Glaxo (now GlaxoSmithKline) and as CEO /President at four companies, including Patheon, Valeant, DSM Pharmaceuticals and Marken. Wheeler joined Marken as CEO in 2011.
During his 40-year professional career, he has been involved in every key functional area in pharmaceuticals, including manufacturing, drug development, supply chain logistics, marketing, and engineering.
Wheeler has a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and a Masters in Business Administration with an emphasis in Finance. He has two adult children and currently lives in North Carolina.